Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.94402979 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.94402979 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.59412175 |
4 | mannose metabolic process (GO:0006013) | 3.93556393 |
5 | positive regulation of p38MAPK cascade (GO:1900745) | 3.92832372 |
6 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.90284637 |
7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.60972298 |
8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.36092362 |
9 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.33468458 |
10 | adherens junction assembly (GO:0034333) | 3.22759914 |
11 | cell-substrate adherens junction assembly (GO:0007045) | 3.21381616 |
12 | focal adhesion assembly (GO:0048041) | 3.21381616 |
13 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.20425312 |
14 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.18846321 |
15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.14597133 |
16 | regulation of p38MAPK cascade (GO:1900744) | 3.12270202 |
17 | stress fiber assembly (GO:0043149) | 3.10868640 |
18 | positive thymic T cell selection (GO:0045059) | 3.07989071 |
19 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.05945339 |
20 | apoptotic process involved in morphogenesis (GO:0060561) | 3.03771056 |
21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.02740511 |
22 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.93839802 |
23 | regulation of early endosome to late endosome transport (GO:2000641) | 2.90440329 |
24 | embryonic process involved in female pregnancy (GO:0060136) | 2.89701580 |
25 | activation of Rac GTPase activity (GO:0032863) | 2.89537224 |
26 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.87648748 |
27 | desmosome organization (GO:0002934) | 2.84856190 |
28 | basement membrane organization (GO:0071711) | 2.84802157 |
29 | semaphorin-plexin signaling pathway (GO:0071526) | 2.84172617 |
30 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.83121570 |
31 | Golgi transport vesicle coating (GO:0048200) | 2.81092256 |
32 | COPI coating of Golgi vesicle (GO:0048205) | 2.81092256 |
33 | germinal center formation (GO:0002467) | 2.80541399 |
34 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80492180 |
35 | positive regulation of receptor recycling (GO:0001921) | 2.79434215 |
36 | response to type I interferon (GO:0034340) | 2.74781864 |
37 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.72734546 |
38 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.72693295 |
39 | response to muramyl dipeptide (GO:0032495) | 2.72531322 |
40 | angiogenesis involved in wound healing (GO:0060055) | 2.72443276 |
41 | barbed-end actin filament capping (GO:0051016) | 2.70210917 |
42 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.69205747 |
43 | positive regulation of histone deacetylation (GO:0031065) | 2.68953757 |
44 | low-density lipoprotein particle clearance (GO:0034383) | 2.68581998 |
45 | positive regulation by symbiont of host defense response (GO:0052509) | 2.67885924 |
46 | modulation by symbiont of host defense response (GO:0052031) | 2.67885924 |
47 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.67885924 |
48 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.67885924 |
49 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.67885924 |
50 | modulation by symbiont of host immune response (GO:0052553) | 2.67885924 |
51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.67876193 |
52 | positive regulation of interferon-alpha production (GO:0032727) | 2.67003087 |
53 | response to peptidoglycan (GO:0032494) | 2.66944880 |
54 | response to laminar fluid shear stress (GO:0034616) | 2.66078284 |
55 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.63700401 |
56 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.62930013 |
57 | type I interferon signaling pathway (GO:0060337) | 2.61956683 |
58 | cellular response to type I interferon (GO:0071357) | 2.61956683 |
59 | negative regulation of cell size (GO:0045792) | 2.61427643 |
60 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.61128324 |
61 | NIK/NF-kappaB signaling (GO:0038061) | 2.58588861 |
62 | endothelial cell chemotaxis (GO:0035767) | 2.57517183 |
63 | activation of MAPKKK activity (GO:0000185) | 2.55623670 |
64 | positive regulation of extracellular matrix organization (GO:1903055) | 2.54944873 |
65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.54541264 |
66 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.53830643 |
67 | regulation of interferon-alpha production (GO:0032647) | 2.53628639 |
68 | skin morphogenesis (GO:0043589) | 2.52734602 |
69 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.51403975 |
70 | atrioventricular valve morphogenesis (GO:0003181) | 2.51046611 |
71 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.49789289 |
72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48620244 |
73 | immunoglobulin mediated immune response (GO:0016064) | 2.47461550 |
74 | wound healing, spreading of epidermal cells (GO:0035313) | 2.46467456 |
75 | hepatocyte apoptotic process (GO:0097284) | 2.44541934 |
76 | morphogenesis of an endothelium (GO:0003159) | 2.44339955 |
77 | endothelial tube morphogenesis (GO:0061154) | 2.44339955 |
78 | negative regulation of stress fiber assembly (GO:0051497) | 2.42482684 |
79 | cell adhesion mediated by integrin (GO:0033627) | 2.42363854 |
80 | natural killer cell differentiation (GO:0001779) | 2.39808842 |
81 | positive regulation of B cell differentiation (GO:0045579) | 2.39092311 |
82 | apoptotic cell clearance (GO:0043277) | 2.38833870 |
83 | regulation of extracellular matrix disassembly (GO:0010715) | 2.38144147 |
84 | cell-cell junction maintenance (GO:0045217) | 2.37984714 |
85 | growth hormone receptor signaling pathway (GO:0060396) | 2.37355153 |
86 | regulation of natural killer cell differentiation (GO:0032823) | 2.36627132 |
87 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.36260560 |
88 | germ cell migration (GO:0008354) | 2.35818454 |
89 | modulation by symbiont of host cellular process (GO:0044068) | 2.34431804 |
90 | establishment of endothelial barrier (GO:0061028) | 2.33833527 |
91 | definitive hemopoiesis (GO:0060216) | 2.33609001 |
92 | activation of JUN kinase activity (GO:0007257) | 2.32513117 |
93 | regulation of integrin activation (GO:0033623) | 2.30913341 |
94 | megakaryocyte development (GO:0035855) | 2.30628721 |
95 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.30061398 |
96 | hemidesmosome assembly (GO:0031581) | 2.29911556 |
97 | decidualization (GO:0046697) | 2.29851811 |
98 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.29601531 |
99 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.29569584 |
100 | response to progesterone (GO:0032570) | 2.29516577 |
101 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.28830277 |
102 | cellular response to arsenic-containing substance (GO:0071243) | 2.28612876 |
103 | regulation of ARF GTPase activity (GO:0032312) | 2.28492812 |
104 | response to fluid shear stress (GO:0034405) | 2.27226711 |
105 | positive regulation of protein dephosphorylation (GO:0035307) | 2.26574476 |
106 | regulation of response to interferon-gamma (GO:0060330) | 2.25189043 |
107 | regulation of erythrocyte differentiation (GO:0045646) | 2.24362729 |
108 | endocytic recycling (GO:0032456) | 2.23308929 |
109 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.23065008 |
110 | negative regulation of fatty acid transport (GO:2000192) | 2.22764941 |
111 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.22523239 |
112 | regulation of cholesterol storage (GO:0010885) | 2.21712084 |
113 | negative regulation of necroptotic process (GO:0060546) | 2.21208185 |
114 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.20995629 |
115 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.20264163 |
116 | negative regulation of viral release from host cell (GO:1902187) | 2.20205664 |
117 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.19844002 |
118 | fibroblast migration (GO:0010761) | 2.19719886 |
119 | regulation of anoikis (GO:2000209) | 2.19336205 |
120 | protein localization to endosome (GO:0036010) | 2.19026621 |
121 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.18579394 |
122 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.17274537 |
123 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.16649613 |
124 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.16366652 |
125 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.16237435 |
126 | positive regulation of interferon-beta production (GO:0032728) | 2.15891658 |
127 | cell volume homeostasis (GO:0006884) | 2.15882359 |
128 | negative regulation of granulocyte differentiation (GO:0030853) | 2.15869763 |
129 | mRNA transcription (GO:0009299) | 2.15574819 |
130 | embryo implantation (GO:0007566) | 2.14765926 |
131 | positive regulation of odontogenesis (GO:0042482) | 2.14727010 |
132 | cellular response to interferon-alpha (GO:0035457) | 2.14721776 |
133 | embryonic hemopoiesis (GO:0035162) | 2.14682891 |
134 | surfactant homeostasis (GO:0043129) | 2.14554106 |
135 | response to interferon-alpha (GO:0035455) | 2.14543933 |
136 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.14424308 |
137 | myeloid dendritic cell differentiation (GO:0043011) | 2.14300670 |
138 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.14289433 |
139 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.13976959 |
140 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.13701512 |
141 | regulation of necrotic cell death (GO:0010939) | 2.13613682 |
142 | regulation of cholesterol homeostasis (GO:2000188) | 2.13289027 |
143 | macrophage activation involved in immune response (GO:0002281) | 2.13207916 |
144 | leukocyte cell-cell adhesion (GO:0007159) | 2.13202445 |
145 | thymic T cell selection (GO:0045061) | 2.13091110 |
146 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.13065604 |
147 | regulation of extracellular matrix organization (GO:1903053) | 2.13012574 |
148 | T cell apoptotic process (GO:0070231) | 2.11606951 |
149 | negative regulation of myotube differentiation (GO:0010832) | 2.11140958 |
150 | pinocytosis (GO:0006907) | 2.09874580 |
151 | hypotonic response (GO:0006971) | 2.09191397 |
152 | glomerular visceral epithelial cell development (GO:0072015) | 2.08923677 |
153 | wound healing, spreading of cells (GO:0044319) | 2.08583383 |
154 | epithelial cell-cell adhesion (GO:0090136) | 2.08387023 |
155 | skeletal muscle adaptation (GO:0043501) | 2.08135169 |
156 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.07756266 |
157 | protein retention in ER lumen (GO:0006621) | 2.07571795 |
158 | actin filament bundle organization (GO:0061572) | 2.07529552 |
159 | actin filament bundle assembly (GO:0051017) | 2.07529552 |
160 | receptor catabolic process (GO:0032801) | 2.06372103 |
161 | positive regulation of macrophage differentiation (GO:0045651) | 2.06224749 |
162 | positive regulation of lipid storage (GO:0010884) | 2.05554217 |
163 | negative regulation of interleukin-12 production (GO:0032695) | 2.05273804 |
164 | cell-substrate junction assembly (GO:0007044) | 2.05104862 |
165 | negative regulation of interleukin-8 production (GO:0032717) | 2.04887315 |
166 | platelet aggregation (GO:0070527) | 2.04142168 |
167 | tolerance induction (GO:0002507) | 2.03939617 |
168 | regulation of necroptotic process (GO:0060544) | 2.03926628 |
169 | response to arsenic-containing substance (GO:0046685) | 2.03681618 |
170 | mesodermal cell differentiation (GO:0048333) | 2.03543263 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.75402731 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.73235949 |
3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.51104198 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.26077424 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.06218800 |
6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.76182458 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.65781885 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.44788382 |
9 | MYC_22102868_ChIP-Seq_BL_Human | 2.34193593 |
10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.28762789 |
11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.23434287 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20917754 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.18470663 |
14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.17572600 |
15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.17405088 |
16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.14773551 |
17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.10696891 |
18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.09514538 |
19 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03659407 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02102781 |
21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.01438727 |
22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01206649 |
23 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00223687 |
24 | * MAF_26560356_Chip-Seq_TH1_Human | 1.96033203 |
25 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94874526 |
26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.94528231 |
27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.89346996 |
28 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.87487434 |
29 | KDM2B_26808549_Chip-Seq_K562_Human | 1.86379753 |
30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.86361879 |
31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83790909 |
32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81643265 |
33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81603696 |
34 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.76560029 |
35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74981210 |
36 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.72601046 |
37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72600997 |
38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.71269139 |
39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.68276984 |
40 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67752586 |
41 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.66506115 |
42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66008513 |
43 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.65501167 |
44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65467800 |
45 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.63856917 |
46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62957701 |
47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61479327 |
48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60946581 |
49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60334914 |
50 | MYB_26560356_Chip-Seq_TH2_Human | 1.60054474 |
51 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59857785 |
52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59700983 |
53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58439133 |
54 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.52328469 |
55 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.51242441 |
56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51012625 |
57 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50635208 |
58 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49819872 |
59 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49359163 |
60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49287686 |
61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49280451 |
62 | MYB_26560356_Chip-Seq_TH1_Human | 1.48237139 |
63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45055850 |
64 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.45037270 |
65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44615324 |
66 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43524492 |
67 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.43432462 |
68 | * P68_20966046_ChIP-Seq_HELA_Human | 1.43177469 |
69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42146851 |
70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40843279 |
71 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.40395522 |
72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40204278 |
73 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.40017728 |
74 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.38878095 |
75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38140170 |
76 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.36838212 |
77 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.35308975 |
78 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34799587 |
79 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.34388125 |
80 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.34388125 |
81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.33275248 |
82 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32890616 |
83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32698619 |
84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32111187 |
85 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.32073871 |
86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.31829635 |
87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31493839 |
88 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.31073808 |
89 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30749824 |
90 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.30230595 |
91 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.29915916 |
92 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29124887 |
93 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28066078 |
94 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.27441288 |
95 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26775920 |
96 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26304745 |
97 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.25993753 |
98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25880729 |
99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.25749743 |
100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25572926 |
101 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.24896044 |
102 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.24840914 |
103 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24587300 |
104 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.24455195 |
105 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21266671 |
106 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.20484865 |
107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20296339 |
108 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20054381 |
109 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17564725 |
110 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17354770 |
111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16936269 |
112 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16891470 |
113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15134358 |
114 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14676905 |
115 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12695357 |
116 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12476622 |
117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11555977 |
118 | MAF_26560356_Chip-Seq_TH2_Human | 1.10603542 |
119 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10228202 |
120 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10160152 |
121 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.07672752 |
122 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.07472815 |
123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06903281 |
124 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06732504 |
125 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06732504 |
126 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05807829 |
127 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04849366 |
128 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04607643 |
129 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.04187834 |
130 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03782191 |
131 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03427577 |
132 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03424877 |
133 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03181596 |
134 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02839976 |
135 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02586136 |
136 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01933353 |
137 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01820918 |
138 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00601101 |
139 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00068858 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 2.98362300 |
2 | MP0005451_abnormal_body_composition | 2.72249357 |
3 | MP0003300_gastrointestinal_ulcer | 2.57255703 |
4 | MP0003303_peritoneal_inflammation | 2.50070654 |
5 | MP0003724_increased_susceptibility_to | 2.30418011 |
6 | MP0003436_decreased_susceptibility_to | 2.30119072 |
7 | MP0004510_myositis | 2.10125439 |
8 | MP0003566_abnormal_cell_adhesion | 2.06835462 |
9 | MP0000685_abnormal_immune_system | 2.03873143 |
10 | MP0006054_spinal_hemorrhage | 2.01781800 |
11 | MP0001835_abnormal_antigen_presentation | 2.01009790 |
12 | MP0010352_gastrointestinal_tract_polyps | 1.98813803 |
13 | MP0003172_abnormal_lysosome_physiology | 1.98413062 |
14 | MP0003705_abnormal_hypodermis_morpholog | 1.97801400 |
15 | MP0000751_myopathy | 1.93724822 |
16 | MP0008260_abnormal_autophagy | 1.93546699 |
17 | MP0005409_darkened_coat_color | 1.91260456 |
18 | MP0002166_altered_tumor_susceptibility | 1.89719327 |
19 | MP0004947_skin_inflammation | 1.89388425 |
20 | MP0001849_ear_inflammation | 1.86616629 |
21 | MP0003656_abnormal_erythrocyte_physiolo | 1.81531764 |
22 | MP0009278_abnormal_bone_marrow | 1.80426825 |
23 | MP0008438_abnormal_cutaneous_collagen | 1.74954830 |
24 | MP0000013_abnormal_adipose_tissue | 1.72822095 |
25 | MP0003828_pulmonary_edema | 1.72279607 |
26 | MP0001853_heart_inflammation | 1.70963870 |
27 | MP0001790_abnormal_immune_system | 1.69136306 |
28 | MP0005387_immune_system_phenotype | 1.69136306 |
29 | MP0002877_abnormal_melanocyte_morpholog | 1.65073293 |
30 | MP0005000_abnormal_immune_tolerance | 1.64696770 |
31 | MP0009785_altered_susceptibility_to | 1.63868993 |
32 | MP0005397_hematopoietic_system_phenotyp | 1.62670035 |
33 | MP0001545_abnormal_hematopoietic_system | 1.62670035 |
34 | MP0000003_abnormal_adipose_tissue | 1.59197839 |
35 | MP0005464_abnormal_platelet_physiology | 1.58510843 |
36 | MP0005375_adipose_tissue_phenotype | 1.58140215 |
37 | MP0005275_abnormal_skin_tensile | 1.56197369 |
38 | MP0001800_abnormal_humoral_immune | 1.54646872 |
39 | MP0010155_abnormal_intestine_physiology | 1.51265077 |
40 | MP0005023_abnormal_wound_healing | 1.50954054 |
41 | MP0005666_abnormal_adipose_tissue | 1.50763771 |
42 | MP0005025_abnormal_response_to | 1.50614322 |
43 | MP0002796_impaired_skin_barrier | 1.49793409 |
44 | MP0002452_abnormal_antigen_presenting | 1.48582132 |
45 | MP0001533_abnormal_skeleton_physiology | 1.48323913 |
46 | MP0002405_respiratory_system_inflammati | 1.46538751 |
47 | MP0002419_abnormal_innate_immunity | 1.43887270 |
48 | MP0002723_abnormal_immune_serum | 1.42140243 |
49 | MP0002254_reproductive_system_inflammat | 1.41914830 |
50 | MP0010368_abnormal_lymphatic_system | 1.41773835 |
51 | MP0001348_abnormal_lacrimal_gland | 1.41541130 |
52 | MP0000465_gastrointestinal_hemorrhage | 1.40964308 |
53 | MP0004808_abnormal_hematopoietic_stem | 1.40924079 |
54 | MP0002006_tumorigenesis | 1.40107167 |
55 | MP0003279_aneurysm | 1.39008503 |
56 | MP0009840_abnormal_foam_cell | 1.35477676 |
57 | MP0004858_abnormal_nervous_system | 1.35229982 |
58 | MP0001958_emphysema | 1.34718016 |
59 | MP0000343_altered_response_to | 1.32502699 |
60 | MP0005076_abnormal_cell_differentiation | 1.31932160 |
61 | MP0001873_stomach_inflammation | 1.31412223 |
62 | MP0002148_abnormal_hypersensitivity_rea | 1.31081564 |
63 | MP0002420_abnormal_adaptive_immunity | 1.30843442 |
64 | MP0001819_abnormal_immune_cell | 1.30669822 |
65 | MP0002396_abnormal_hematopoietic_system | 1.30073053 |
66 | MP0003763_abnormal_thymus_physiology | 1.28947982 |
67 | MP0005671_abnormal_response_to | 1.26826733 |
68 | MP0002138_abnormal_hepatobiliary_system | 1.25541622 |
69 | MP0001845_abnormal_inflammatory_respons | 1.25120552 |
70 | MP0002398_abnormal_bone_marrow | 1.24927601 |
71 | MP0004084_abnormal_cardiac_muscle | 1.24150892 |
72 | MP0003453_abnormal_keratinocyte_physiol | 1.23798520 |
73 | MP0002933_joint_inflammation | 1.23735073 |
74 | MP0003191_abnormal_cellular_cholesterol | 1.23293281 |
75 | MP0003075_altered_response_to | 1.20692798 |
76 | MP0001879_abnormal_lymphatic_vessel | 1.20538911 |
77 | MP0000678_abnormal_parathyroid_gland | 1.19521274 |
78 | MP0006138_congestive_heart_failure | 1.19183942 |
79 | MP0003448_altered_tumor_morphology | 1.17576160 |
80 | MP0009333_abnormal_splenocyte_physiolog | 1.16683449 |
81 | MP0002060_abnormal_skin_morphology | 1.16044611 |
82 | MP0005257_abnormal_intraocular_pressure | 1.15084385 |
83 | MP0000767_abnormal_smooth_muscle | 1.13925414 |
84 | MP0000750_abnormal_muscle_regeneration | 1.13439988 |
85 | MP0000858_altered_metastatic_potential | 1.12371001 |
86 | MP0003091_abnormal_cell_migration | 1.11752314 |
87 | MP0004233_abnormal_muscle_weight | 1.11742668 |
88 | MP0005670_abnormal_white_adipose | 1.11728332 |
89 | MP0004147_increased_porphyrin_level | 1.11145445 |
90 | MP0002722_abnormal_immune_system | 1.09143277 |
91 | MP0000716_abnormal_immune_system | 1.09088023 |
92 | MP0000689_abnormal_spleen_morphology | 1.06905035 |
93 | MP0006082_CNS_inflammation | 1.04684826 |
94 | MP0004381_abnormal_hair_follicle | 1.03651669 |
95 | MP0009764_decreased_sensitivity_to | 1.03181424 |
96 | MP0002429_abnormal_blood_cell | 1.03002179 |
97 | MP0005501_abnormal_skin_physiology | 1.02323154 |
98 | MP0003866_abnormal_defecation | 1.01930307 |
99 | MP0008469_abnormal_protein_level | 1.00620296 |
100 | MP0005330_cardiomyopathy | 0.99792162 |
101 | MP0000747_muscle_weakness | 0.99676595 |
102 | MP0002896_abnormal_bone_mineralization | 0.99220945 |
103 | MP0009384_cardiac_valve_regurgitation | 0.99049209 |
104 | MP0000759_abnormal_skeletal_muscle | 0.99018821 |
105 | MP0004185_abnormal_adipocyte_glucose | 0.97202113 |
106 | MP0010234_abnormal_vibrissa_follicle | 0.97019147 |
107 | MP0008775_abnormal_heart_ventricle | 0.96668058 |
108 | MP0000249_abnormal_blood_vessel | 0.95199557 |
109 | MP0002998_abnormal_bone_remodeling | 0.94741105 |
110 | MP0001851_eye_inflammation | 0.93612253 |
111 | MP0003329_amyloid_beta_deposits | 0.92889704 |
112 | MP0005390_skeleton_phenotype | 0.92756546 |
113 | MP0010630_abnormal_cardiac_muscle | 0.91483879 |
114 | MP0005166_decreased_susceptibility_to | 0.90850286 |
115 | MP0000490_abnormal_crypts_of | 0.89422968 |
116 | MP0005165_increased_susceptibility_to | 0.88867952 |
117 | MP0004272_abnormal_basement_membrane | 0.87842438 |
118 | MP0008961_abnormal_basal_metabolism | 0.86995458 |
119 | MP0000609_abnormal_liver_physiology | 0.86377224 |
120 | MP0010307_abnormal_tumor_latency | 0.86316506 |
121 | MP0005083_abnormal_biliary_tract | 0.84292359 |
122 | MP0005164_abnormal_response_to | 0.83558292 |
123 | MP0001243_abnormal_dermal_layer | 0.83409308 |
124 | MP0002136_abnormal_kidney_physiology | 0.82584904 |
125 | MP0000703_abnormal_thymus_morphology | 0.82583241 |
126 | MP0009931_abnormal_skin_appearance | 0.81689031 |
127 | MP0005167_abnormal_blood-brain_barrier | 0.81262782 |
128 | MP0004087_abnormal_muscle_fiber | 0.80782057 |
129 | MP0002332_abnormal_exercise_endurance | 0.80190674 |
130 | MP0002139_abnormal_hepatobiliary_system | 0.80154927 |
131 | MP0000604_amyloidosis | 0.80074416 |
132 | MP0003045_fibrosis | 0.79573220 |
133 | MP0000733_abnormal_muscle_development | 0.79493682 |
134 | MP0003795_abnormal_bone_structure | 0.79195589 |
135 | MP0001216_abnormal_epidermal_layer | 0.78600311 |
136 | MP0002089_abnormal_postnatal_growth/wei | 0.77747240 |
137 | MP0005595_abnormal_vascular_smooth | 0.77675753 |
138 | MP0004130_abnormal_muscle_cell | 0.77283073 |
139 | MP0005621_abnormal_cell_physiology | 0.74639067 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased connective tissue (HP:0009025) | 3.33079928 |
2 | Broad face (HP:0000283) | 3.32640038 |
3 | Polycythemia (HP:0001901) | 3.25317443 |
4 | Eczematoid dermatitis (HP:0000976) | 3.12131325 |
5 | Interstitial pulmonary disease (HP:0006530) | 3.01623621 |
6 | Abnormality of the nasal mucosa (HP:0000433) | 3.00052510 |
7 | Obstructive sleep apnea (HP:0002870) | 2.96689228 |
8 | Cerebral aneurysm (HP:0004944) | 2.96275599 |
9 | Petechiae (HP:0000967) | 2.94026124 |
10 | Muscle fiber splitting (HP:0003555) | 2.91869421 |
11 | Aortic aneurysm (HP:0004942) | 2.87881079 |
12 | Myocardial infarction (HP:0001658) | 2.79205175 |
13 | Pustule (HP:0200039) | 2.73020130 |
14 | Hematochezia (HP:0002573) | 2.70965407 |
15 | Tetraparesis (HP:0002273) | 2.69990159 |
16 | Premature rupture of membranes (HP:0001788) | 2.69830285 |
17 | Hyperacusis (HP:0010780) | 2.68088625 |
18 | Achilles tendon contracture (HP:0001771) | 2.65350636 |
19 | Dysostosis multiplex (HP:0000943) | 2.64518810 |
20 | Abnormality of glycolipid metabolism (HP:0010969) | 2.64449661 |
21 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.64449661 |
22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.64449661 |
23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.62708886 |
24 | Autoimmune thrombocytopenia (HP:0001973) | 2.61875534 |
25 | Right ventricular cardiomyopathy (HP:0011663) | 2.61772856 |
26 | Protrusio acetabuli (HP:0003179) | 2.59604627 |
27 | Nasal polyposis (HP:0100582) | 2.58628691 |
28 | J-shaped sella turcica (HP:0002680) | 2.58570120 |
29 | Spontaneous hematomas (HP:0007420) | 2.55621785 |
30 | Chronic otitis media (HP:0000389) | 2.53498951 |
31 | Distal upper limb amyotrophy (HP:0007149) | 2.51636765 |
32 | Upper limb amyotrophy (HP:0009129) | 2.51636765 |
33 | Nuclear cataract (HP:0100018) | 2.51375899 |
34 | Difficulty climbing stairs (HP:0003551) | 2.51203380 |
35 | Ulnar bowing (HP:0003031) | 2.51079221 |
36 | Abnormal platelet volume (HP:0011876) | 2.47177601 |
37 | Abnormal platelet function (HP:0011869) | 2.46298884 |
38 | Impaired platelet aggregation (HP:0003540) | 2.46298884 |
39 | Prolonged bleeding time (HP:0003010) | 2.45519455 |
40 | Increased mean platelet volume (HP:0011877) | 2.44502248 |
41 | Increased IgE level (HP:0003212) | 2.42825680 |
42 | Abnormality of the Achilles tendon (HP:0005109) | 2.39495656 |
43 | Lower limb amyotrophy (HP:0007210) | 2.38225131 |
44 | Axonal loss (HP:0003447) | 2.37744629 |
45 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.36063723 |
46 | Mucopolysacchariduria (HP:0008155) | 2.36063723 |
47 | Cellulitis (HP:0100658) | 2.33158083 |
48 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.33075991 |
49 | Osteolytic defects of the hand bones (HP:0009699) | 2.33075991 |
50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.32464067 |
51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.32464067 |
52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.32464067 |
53 | Hyporeflexia of lower limbs (HP:0002600) | 2.29563726 |
54 | Increased density of long bones (HP:0006392) | 2.29403183 |
55 | Aortic dissection (HP:0002647) | 2.29153550 |
56 | Poikilocytosis (HP:0004447) | 2.28488589 |
57 | Ventricular tachycardia (HP:0004756) | 2.27045352 |
58 | Stridor (HP:0010307) | 2.24582890 |
59 | Increased variability in muscle fiber diameter (HP:0003557) | 2.21923822 |
60 | Distal lower limb amyotrophy (HP:0008944) | 2.20794489 |
61 | Myositis (HP:0100614) | 2.20561405 |
62 | Recurrent viral infections (HP:0004429) | 2.20008236 |
63 | Emphysema (HP:0002097) | 2.19054587 |
64 | Malnutrition (HP:0004395) | 2.17820193 |
65 | Recurrent fungal infections (HP:0002841) | 2.17712002 |
66 | Peritonitis (HP:0002586) | 2.17090359 |
67 | Epistaxis (HP:0000421) | 2.16637878 |
68 | Hemorrhage of the eye (HP:0011885) | 2.15269419 |
69 | Recurrent abscess formation (HP:0002722) | 2.14844045 |
70 | Joint stiffness (HP:0001387) | 2.14420414 |
71 | Mitral regurgitation (HP:0001653) | 2.14404077 |
72 | Shallow orbits (HP:0000586) | 2.12370082 |
73 | Flat acetabular roof (HP:0003180) | 2.10579289 |
74 | Dilatation of the ascending aorta (HP:0005111) | 2.10452309 |
75 | Thrombocytosis (HP:0001894) | 2.08827119 |
76 | Distal lower limb muscle weakness (HP:0009053) | 2.07844798 |
77 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.07803876 |
78 | Increased serum ferritin (HP:0003281) | 2.07037798 |
79 | Menorrhagia (HP:0000132) | 2.06981547 |
80 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.06527816 |
81 | Aneurysm (HP:0002617) | 2.05997306 |
82 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.05977973 |
83 | Colitis (HP:0002583) | 2.03394400 |
84 | Wormian bones (HP:0002645) | 2.02940475 |
85 | Vertebral compression fractures (HP:0002953) | 2.01847204 |
86 | Diaphragmatic weakness (HP:0009113) | 2.01131479 |
87 | Persistence of primary teeth (HP:0006335) | 2.00818220 |
88 | Short nail (HP:0001799) | 2.00325039 |
89 | Reticulocytosis (HP:0001923) | 1.99608325 |
90 | Facial diplegia (HP:0001349) | 1.98598101 |
91 | Orchitis (HP:0100796) | 1.95373625 |
92 | Blue sclerae (HP:0000592) | 1.95288012 |
93 | Mitral valve prolapse (HP:0001634) | 1.94880223 |
94 | Asymmetric septal hypertrophy (HP:0001670) | 1.94612744 |
95 | Aortic regurgitation (HP:0001659) | 1.93175454 |
96 | Exercise-induced myalgia (HP:0003738) | 1.93124942 |
97 | Gingival bleeding (HP:0000225) | 1.93073581 |
98 | Recurrent bacterial skin infections (HP:0005406) | 1.92793705 |
99 | Rectal prolapse (HP:0002035) | 1.92540606 |
100 | Loss of speech (HP:0002371) | 1.91862084 |
101 | Nonimmune hydrops fetalis (HP:0001790) | 1.90703957 |
102 | Atrophic scars (HP:0001075) | 1.89045277 |
103 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87913301 |
104 | Recurrent bronchitis (HP:0002837) | 1.87760560 |
105 | Arterial thrombosis (HP:0004420) | 1.86081517 |
106 | Neurofibrillary tangles (HP:0002185) | 1.84591691 |
107 | Cerebral inclusion bodies (HP:0100314) | 1.84364420 |
108 | Disproportionate tall stature (HP:0001519) | 1.84278259 |
109 | Esophageal varix (HP:0002040) | 1.84070482 |
110 | Abnormality of iron homeostasis (HP:0011031) | 1.83767912 |
111 | Cervical subluxation (HP:0003308) | 1.83370061 |
112 | Lipoatrophy (HP:0100578) | 1.83047815 |
113 | Myopathic facies (HP:0002058) | 1.82700273 |
114 | Biconcave vertebral bodies (HP:0004586) | 1.82212647 |
115 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.81987282 |
116 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.80113829 |
117 | Hydroxyprolinuria (HP:0003080) | 1.79362423 |
118 | Abnormality of proline metabolism (HP:0010907) | 1.79362423 |
119 | Round ear (HP:0100830) | 1.77866861 |
120 | Spondylolisthesis (HP:0003302) | 1.77303512 |
121 | Increased cerebral lipofuscin (HP:0011813) | 1.76967192 |
122 | Thin bony cortex (HP:0002753) | 1.75757791 |
123 | Elbow flexion contracture (HP:0002987) | 1.75515927 |
124 | Inflammation of the large intestine (HP:0002037) | 1.75063248 |
125 | Ankle contracture (HP:0006466) | 1.74619438 |
126 | Broad metatarsal (HP:0001783) | 1.74573740 |
127 | Fragile skin (HP:0001030) | 1.74434229 |
128 | Limb-girdle muscle atrophy (HP:0003797) | 1.73175169 |
129 | Genu recurvatum (HP:0002816) | 1.72724536 |
130 | Gastrointestinal inflammation (HP:0004386) | 1.72162178 |
131 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.71175784 |
132 | Mesangial abnormality (HP:0001966) | 1.70592729 |
133 | Abnormality of macrophages (HP:0004311) | 1.70476153 |
134 | Subacute progressive viral hepatitis (HP:0006572) | 1.70420414 |
135 | Arterial tortuosity (HP:0005116) | 1.70362433 |
136 | Bicuspid aortic valve (HP:0001647) | 1.70138558 |
137 | Onion bulb formation (HP:0003383) | 1.69716334 |
138 | Vascular tortuosity (HP:0004948) | 1.69414389 |
139 | Bladder diverticulum (HP:0000015) | 1.68934190 |
140 | Bulbar palsy (HP:0001283) | 1.68854198 |
141 | Long palpebral fissure (HP:0000637) | 1.68773695 |
142 | Spinal rigidity (HP:0003306) | 1.68434910 |
143 | Acanthosis nigricans (HP:0000956) | 1.68429666 |
144 | Hypertriglyceridemia (HP:0002155) | 1.68337170 |
145 | Purpura (HP:0000979) | 1.67869164 |
146 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67049987 |
147 | Vasculitis (HP:0002633) | 1.66970937 |
148 | Nephritis (HP:0000123) | 1.66702533 |
149 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.66700825 |
150 | Type 1 muscle fiber predominance (HP:0003803) | 1.66351170 |
151 | Abnormality of the fingertips (HP:0001211) | 1.66052699 |
152 | IgM deficiency (HP:0002850) | 1.63802532 |
153 | Acanthocytosis (HP:0001927) | 1.63425571 |
154 | EMG: myopathic abnormalities (HP:0003458) | 1.63192019 |
155 | Deformed sella turcica (HP:0002681) | 1.63133380 |
156 | Mediastinal lymphadenopathy (HP:0100721) | 1.63073254 |
157 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.63009240 |
158 | Abnormality of the thoracic spine (HP:0100711) | 1.62762442 |
159 | Bone pain (HP:0002653) | 1.61853508 |
160 | Easy fatigability (HP:0003388) | 1.60621393 |
161 | Generalized amyotrophy (HP:0003700) | 1.60362811 |
162 | Advanced eruption of teeth (HP:0006288) | 1.60254775 |
163 | Natal tooth (HP:0000695) | 1.58905190 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PRPF4B | 3.21652881 |
2 | ERN1 | 3.12731580 |
3 | TRIB3 | 3.05676395 |
4 | MAP4K1 | 2.70100653 |
5 | TTN | 2.41177822 |
6 | TBK1 | 2.38857246 |
7 | EPHB1 | 2.24730964 |
8 | ICK | 2.22138601 |
9 | EEF2K | 2.20574963 |
10 | TYK2 | 2.18328224 |
11 | FGFR4 | 2.16878501 |
12 | MAP3K10 | 2.13409734 |
13 | TGFBR2 | 2.09748066 |
14 | MAP3K3 | 2.04879829 |
15 | PKN2 | 2.03818231 |
16 | SMG1 | 1.95652321 |
17 | STK10 | 1.93127862 |
18 | JAK3 | 1.92022806 |
19 | MAP3K14 | 1.91971962 |
20 | PIM2 | 1.75879525 |
21 | RIPK1 | 1.74807970 |
22 | LRRK2 | 1.70430160 |
23 | TAOK2 | 1.64390593 |
24 | TIE1 | 1.61081847 |
25 | IKBKB | 1.59624918 |
26 | IKBKE | 1.56473227 |
27 | EPHA3 | 1.55113434 |
28 | MAP2K3 | 1.54901718 |
29 | MAP3K13 | 1.54493554 |
30 | ZAP70 | 1.53414092 |
31 | PTK6 | 1.48662571 |
32 | MAPKAPK3 | 1.43589508 |
33 | RPS6KA4 | 1.41130335 |
34 | JAK1 | 1.40043921 |
35 | TAOK3 | 1.37265384 |
36 | KDR | 1.35495198 |
37 | DMPK | 1.32320390 |
38 | CDC42BPA | 1.29473030 |
39 | KIT | 1.29321402 |
40 | CHUK | 1.29304988 |
41 | NME2 | 1.24207491 |
42 | PIM1 | 1.22327459 |
43 | MARK2 | 1.22184398 |
44 | TRPM7 | 1.17507418 |
45 | MST4 | 1.17169881 |
46 | ITK | 1.16124323 |
47 | IRAK3 | 1.15409961 |
48 | LATS2 | 1.15166297 |
49 | TESK1 | 1.14749687 |
50 | PRKD2 | 1.11556277 |
51 | MAP3K6 | 1.10395253 |
52 | FLT3 | 1.08330654 |
53 | CSK | 1.07375912 |
54 | DDR2 | 1.06271324 |
55 | BTK | 1.05178819 |
56 | MAP3K11 | 1.03876405 |
57 | FGFR3 | 1.03008729 |
58 | SIK1 | 1.01664103 |
59 | MST1R | 1.01072927 |
60 | MET | 0.99773521 |
61 | CDK12 | 0.96011033 |
62 | PDPK1 | 0.94239543 |
63 | TAOK1 | 0.94201216 |
64 | RPS6KA2 | 0.92410849 |
65 | PAK2 | 0.91718701 |
66 | TEC | 0.90041059 |
67 | BMX | 0.89590178 |
68 | TGFBR1 | 0.87527818 |
69 | JAK2 | 0.87063985 |
70 | EPHA2 | 0.85059935 |
71 | HCK | 0.83727468 |
72 | PDGFRA | 0.80634814 |
73 | GRK6 | 0.80562741 |
74 | MAPK15 | 0.80529857 |
75 | MAPK12 | 0.79909310 |
76 | NLK | 0.79810557 |
77 | RPS6KB2 | 0.79033579 |
78 | LMTK2 | 0.77755015 |
79 | MAP2K2 | 0.77203976 |
80 | SYK | 0.76533877 |
81 | MYLK | 0.75660101 |
82 | BLK | 0.75488522 |
83 | IRAK2 | 0.74603666 |
84 | MARK3 | 0.73293377 |
85 | TXK | 0.73148102 |
86 | SIK3 | 0.69415822 |
87 | MAPKAPK2 | 0.67271572 |
88 | ARAF | 0.66330630 |
89 | RIPK4 | 0.65926687 |
90 | MAPK11 | 0.65725648 |
91 | HIPK2 | 0.65364498 |
92 | STK4 | 0.64932044 |
93 | DYRK1B | 0.64718578 |
94 | PDGFRB | 0.64127894 |
95 | SIK2 | 0.62899035 |
96 | PRKG2 | 0.62810074 |
97 | PAK4 | 0.62449626 |
98 | STK38 | 0.61577554 |
99 | MAP3K7 | 0.61559774 |
100 | MTOR | 0.59741384 |
101 | MAPK7 | 0.58903194 |
102 | KSR2 | 0.57980036 |
103 | MAP2K6 | 0.57794735 |
104 | MAP3K1 | 0.57631173 |
105 | LCK | 0.57218894 |
106 | NTRK1 | 0.55080238 |
107 | STK3 | 0.55063459 |
108 | CDK6 | 0.54641238 |
109 | STK24 | 0.53363556 |
110 | RPS6KA6 | 0.53319256 |
111 | MAP3K8 | 0.51697526 |
112 | MAPK4 | 0.50774402 |
113 | DYRK3 | 0.50490441 |
114 | NEK9 | 0.49637008 |
115 | PTK2 | 0.49430088 |
116 | PDK1 | 0.48664372 |
117 | ABL2 | 0.47840541 |
118 | TNK2 | 0.47348381 |
119 | MOS | 0.47289118 |
120 | GSK3A | 0.47253278 |
121 | CSF1R | 0.47141558 |
122 | CAMK1D | 0.44338831 |
123 | PRKAA2 | 0.44168817 |
124 | RPS6KC1 | 0.41821599 |
125 | RPS6KL1 | 0.41821599 |
126 | ILK | 0.41688606 |
127 | RPS6KA5 | 0.40912187 |
128 | MAP3K9 | 0.40223677 |
129 | ABL1 | 0.38877362 |
130 | IRAK4 | 0.38452783 |
131 | SCYL2 | 0.38411763 |
132 | RPS6KA1 | 0.38094369 |
133 | PRKD3 | 0.37978173 |
134 | CDK9 | 0.37846601 |
135 | PRKD1 | 0.37119058 |
136 | CDK4 | 0.37094067 |
137 | EPHB2 | 0.37053519 |
138 | IRAK1 | 0.33214891 |
139 | CAMKK1 | 0.32079046 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.36589460 |
2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.30795544 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19388700 |
4 | Malaria_Homo sapiens_hsa05144 | 2.16744124 |
5 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.93613648 |
6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83240218 |
7 | Measles_Homo sapiens_hsa05162 | 1.82796338 |
8 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82194131 |
9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81748937 |
10 | Legionellosis_Homo sapiens_hsa05134 | 1.75653140 |
11 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.74351826 |
12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72970571 |
13 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.70591473 |
14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67087614 |
15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66365619 |
16 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.64122455 |
17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63515339 |
18 | Apoptosis_Homo sapiens_hsa04210 | 1.62474944 |
19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.53544932 |
20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53418454 |
21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.50414917 |
22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50103756 |
23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.45082534 |
24 | Influenza A_Homo sapiens_hsa05164 | 1.43829407 |
25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.43355402 |
26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42456605 |
27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41623755 |
28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37229076 |
29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35323435 |
30 | Focal adhesion_Homo sapiens_hsa04510 | 1.32052094 |
31 | Amoebiasis_Homo sapiens_hsa05146 | 1.31327697 |
32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28668238 |
33 | Pertussis_Homo sapiens_hsa05133 | 1.27397693 |
34 | Prion diseases_Homo sapiens_hsa05020 | 1.26299403 |
35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.25708749 |
36 | Hepatitis B_Homo sapiens_hsa05161 | 1.25237359 |
37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23005623 |
38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.20351171 |
39 | Insulin resistance_Homo sapiens_hsa04931 | 1.19610572 |
40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.18493107 |
41 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.16219753 |
42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14937587 |
43 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.14852530 |
44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.14182214 |
45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12543771 |
46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.12411571 |
47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.12179729 |
48 | Platelet activation_Homo sapiens_hsa04611 | 1.09610661 |
49 | Tuberculosis_Homo sapiens_hsa05152 | 1.08562846 |
50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06596393 |
51 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.06189179 |
52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06121498 |
53 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.05153529 |
54 | Shigellosis_Homo sapiens_hsa05131 | 1.04605429 |
55 | Hepatitis C_Homo sapiens_hsa05160 | 1.04346188 |
56 | Bladder cancer_Homo sapiens_hsa05219 | 1.03309689 |
57 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.02347992 |
58 | Salmonella infection_Homo sapiens_hsa05132 | 1.01262109 |
59 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00673563 |
60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00524936 |
61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99080551 |
62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97524718 |
63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95887279 |
64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95807847 |
65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93082545 |
66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92976090 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91004116 |
68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90437731 |
69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.89983236 |
70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89337448 |
71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89250508 |
72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.89188333 |
73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.88960205 |
74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.88534813 |
75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86962309 |
76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86079612 |
77 | Glioma_Homo sapiens_hsa05214 | 0.85671491 |
78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85558373 |
79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84332055 |
80 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.83125587 |
81 | Adherens junction_Homo sapiens_hsa04520 | 0.82426712 |
82 | Endocytosis_Homo sapiens_hsa04144 | 0.81424326 |
83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.81309114 |
84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80383017 |
85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77151881 |
86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77069320 |
87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76290675 |
88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75140251 |
89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75049932 |
90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74286610 |
91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73579561 |
92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72960541 |
93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72803522 |
94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72745811 |
95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72187229 |
96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71988966 |
97 | Allograft rejection_Homo sapiens_hsa05330 | 0.71459129 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71452831 |
99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70066293 |
100 | Lysosome_Homo sapiens_hsa04142 | 0.69821299 |
101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68965539 |
102 | ABC transporters_Homo sapiens_hsa02010 | 0.68791069 |
103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68057031 |
104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67775014 |
105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64657840 |
106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64563215 |
107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61009671 |
108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60416037 |
109 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60064353 |
110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58343593 |
111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57663922 |
112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56850439 |
113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56285779 |
114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54188958 |
115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53282598 |
116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53281525 |
117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52692693 |
118 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.52539141 |
119 | Prostate cancer_Homo sapiens_hsa05215 | 0.52391700 |
120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52371869 |
121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52203624 |
122 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49888872 |
123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49615749 |
124 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49275882 |
125 | Lysine degradation_Homo sapiens_hsa00310 | 0.49061458 |
126 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48626602 |
127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46776314 |
128 | Asthma_Homo sapiens_hsa05310 | 0.43382891 |
129 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43089449 |
130 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42747104 |
131 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40419620 |
132 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40417181 |